4//SEC Filing
Jolly Douglas 4
Accession 0001209191-19-033202
CIK 0001419041other
Filed
May 28, 8:00 PM ET
Accepted
May 29, 4:32 PM ET
Size
8.3 KB
Accession
0001209191-19-033202
Insider Transaction Report
Form 4
Tocagen IncTOCA
Jolly Douglas
EVP, Research & Pharm Devel
Transactions
- Award
Common Stock
2018-12-10$8.19/sh+732$5,995→ 393,478 total - Award
Common Stock
2018-06-08$8.19/sh+703$5,758→ 392,746 total
Holdings
- 21,739(indirect: By daughter)
Common Stock
- 21,739(indirect: By son)
Common Stock
Footnotes (3)
- [F1]This Form 4 is being filed voluntarily to report the acquisition of 703 shares by the Reporting Person on June 8, 2018 pursuant to the Issuer's Employee Stock Purchase Plan.
- [F2]This Form 4 is being filed voluntarily to report the acquisition of 732 shares by the Reporting Person on December 10, 2018 pursuant to the Issuer's Employee Stock Purchase Plan.
- [F3]The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Documents
Issuer
Tocagen Inc
CIK 0001419041
Entity typeother
Related Parties
1- filerCIK 0001701643
Filing Metadata
- Form type
- 4
- Filed
- May 28, 8:00 PM ET
- Accepted
- May 29, 4:32 PM ET
- Size
- 8.3 KB